Prescription Drug Information: Lithium Carbonate (Page 5 of 5)

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Lithium carbonate 150 mg container label — 100s count

lithiumcarbonate150mg100scount
(click image for full-size original)

Lithium carbonate 300 mg container label — 100s count

lithiumcarbonate300mg100scount
(click image for full-size original)

Lithium carbonate 600 mg container label — 100s count

lithiumcarbonate600mg100scount
(click image for full-size original)
LITHIUM CARBONATE lithium carbonate capsule
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:31722-544
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
LITHIUM CARBONATE (LITHIUM CATION) LITHIUM CARBONATE 150 mg
Inactive Ingredients
Ingredient Name Strength
GELATIN
SODIUM LAURYL SULFATE
TALC
TITANIUM DIOXIDE
FERROSOFERRIC OXIDE
BUTYL ALCOHOL
ALCOHOL
ISOPROPYL ALCOHOL
POTASSIUM HYDROXIDE
PROPYLENE GLYCOL
AMMONIA
SHELLAC
Product Characteristics
Color white Score no score
Shape CAPSULE Size 14mm
Flavor Imprint Code 97;H
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:31722-544-30 30 CAPSULE in 1 BOTTLE None
2 NDC:31722-544-01 100 CAPSULE in 1 BOTTLE None
3 NDC:31722-544-05 500 CAPSULE in 1 BOTTLE None
4 NDC:31722-544-10 1000 CAPSULE in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA090702 12/15/2009
LITHIUM CARBONATE lithium carbonate capsule
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:31722-545
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
LITHIUM CARBONATE (LITHIUM CATION) LITHIUM CARBONATE 300 mg
Inactive Ingredients
Ingredient Name Strength
GELATIN
SODIUM LAURYL SULFATE
TALC
TITANIUM DIOXIDE
FERROSOFERRIC OXIDE
BUTYL ALCOHOL
ALCOHOL
ISOPROPYL ALCOHOL
POTASSIUM HYDROXIDE
PROPYLENE GLYCOL
SHELLAC
AMMONIA
Product Characteristics
Color pink Score no score
Shape CAPSULE Size 20mm
Flavor Imprint Code 98;H
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:31722-545-30 30 CAPSULE in 1 BOTTLE None
2 NDC:31722-545-01 100 CAPSULE in 1 BOTTLE None
3 NDC:31722-545-05 500 CAPSULE in 1 BOTTLE None
4 NDC:31722-545-10 1000 CAPSULE in 1 BOTTLE None
5 NDC:31722-545-50 5000 CAPSULE in 1 BOTTLE None
6 NDC:31722-545-03 30 CAPSULE in 1 BLISTER PACK None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA090702 12/15/2009
LITHIUM CARBONATE lithium carbonate capsule
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:31722-546
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
LITHIUM CARBONATE (LITHIUM CATION) LITHIUM CARBONATE 600 mg
Inactive Ingredients
Ingredient Name Strength
GELATIN
SODIUM LAURYL SULFATE
TALC
TITANIUM DIOXIDE
FERROSOFERRIC OXIDE
BUTYL ALCOHOL
ALCOHOL
ISOPROPYL ALCOHOL
POTASSIUM HYDROXIDE
PROPYLENE GLYCOL
SHELLAC
AMMONIA
Product Characteristics
Color pink, white Score no score
Shape CAPSULE Size 22mm
Flavor Imprint Code 141;H
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:31722-546-30 30 CAPSULE in 1 BOTTLE None
2 NDC:31722-546-01 100 CAPSULE in 1 BOTTLE None
3 NDC:31722-546-05 500 CAPSULE in 1 BOTTLE None
4 NDC:31722-546-10 1000 CAPSULE in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA090702 12/15/2009
Labeler — Camber Pharmaceuticals, Inc. (826774775)
Establishment
Name Address ID/FEI Operations
Hetero Labs Limited Unit III 676162024 analysis (31722-546), relabel (31722-546), repack (31722-544), repack (31722-545), manufacture (31722-546)

Revised: 06/2021 Camber Pharmaceuticals, Inc.

RxDrugLabels.com provides trustworthy package insert and label information about marketed prescription drugs as submitted by manufacturers to the U.S. Food and Drug Administration. Package information is not reviewed or updated separately by RxDrugLabels.com. Every individual prescription drug label and package insert entry contains a unique identifier which can be used to secure further details directly from the U.S. National Institutes of Health and/or the FDA.

Medication Sections

Medication Information by RSS

As a leading independent provider of trustworthy medication information, we source our database directly from the FDA's central repository of drug labels and package inserts under the Structured Product Labeling standard. RxDrugLabels.com provides the full prescription-only subset of the FDA's repository. Medication information provided here is not intended as a substitute for direct consultation with a qualified health professional.

Terms of Use | Copyright © 2021. All Rights Reserved.